---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-26-000021"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:43:34.134479+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GeneDx enters $100M term loan with Blackstone to repay existing credit facility

## Summary
- $100M term loan funded Feb 27, 2026; proceeds used to repay existing Perceptive Credit term loan.
- Interest rate at Term SOFR + 4.50% (1.50% floor); matures in five years.
- Mandatory prepayment triggers include change of control, additional debt, asset sales.
- Secured by first lien on substantially all assets; includes $50M minimum liquidity covenant.
- Proceeds also for balance sheet optimization and general corporate purposes.

## SEC filing metadata
- accession: 0001818331-26-000021
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/0001818331-26-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/wgs-20260227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-26-000021
- JSON: https://secwatch.observer/filing/0001818331-26-000021.json
- Plain text: https://secwatch.observer/filing/0001818331-26-000021.txt

## Source-grounded claims
- claim_id: 21d346d3598761e082b5e2091106b86dbde17ee1
  claim: GeneDx Holdings Corp. incurred term loan of $100.0 million with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C. (collectively, the “Blackstone Representative”) at Term SOFR adjusted secured overnight financing rate plus a margin of 4.50% maturing five years from the Closing Date.
  evidence_excerpt: The Loan Agreement provides for a term loan in an aggregate principal amount of $100.0 million funded to the Company on the Closing Date (the “Term Loan”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/0001818331-26-000021-index.htm
- claim_id: 465e62de7b20bf8b913739283afd452a0701ab4a
  claim: GeneDx Holdings Corp. terminated Existing Credit Agreement with Perceptive Credit Holdings IV, LP valued at Repayment in full of existing term loan (effective 2026-02-27).
  evidence_excerpt: The proceeds of the Term Loan were used to repay in full the Company’s existing term loan under its existing Credit Agreement and Guaranty, dated as of October 27, 2023, by and among Sema4 OpCo, Inc. and GeneDx, LLC, as Borrowers, the guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit Holdings IV, LP as the administrative agent and as a lender (the “Existing Credit Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/0001818331-26-000021-index.htm
- claim_id: 94836d3efa850261f39e5a2371ef83165498037b
  claim: GeneDx Holdings Corp. entered into Loan Agreement with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C. valued at $100.0 million term loan (effective 2026-02-27).
  evidence_excerpt: On February 27, 2026 (the “Closing Date”), GeneDx Holdings Corp. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”), with Blackstone Alternative Credit Advisors LP and Blackstone Life Sciences Advisors L.L.C. (collectively, the “Blackstone Representative” and referred to herein as “Blackstone”), certain subsidiaries of the Company party thereto as Guarantors, Wilmington Trust, National Association, as Agent and the lenders from time to time party thereto (collectively, the “Lenders”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833126000021/0001818331-26-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.